Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Combination therapy utilizing ketamine and transcranial magnetic stimulation for treatment-resistant depression: a case report.

Best SR, Griffin B.

Int J Neurosci. 2015 Mar;125(3):232-4. doi: 10.3109/00207454.2014.933834. Epub 2014 Jul 23.

PMID:
24927244
2.

Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.

Abdallah CG, Fasula M, Kelmendi B, Sanacora G, Ostroff R.

J ECT. 2012 Sep;28(3):157-61. doi: 10.1097/YCT.0b013e31824f8296.

3.

Remission of treatment-resistant depression with electroconvulsive therapy and ketamine.

Niemegeers P, Schrijvers D, Madani Y, Sabbe BG.

J ECT. 2014 Sep;30(3):e31-2. doi: 10.1097/YCT.0000000000000104. No abstract available.

PMID:
24625710
4.

Combined ketamine/transcranial magnetic stimulation treatment of severe depression in bipolar I disorder.

Best SR.

J ECT. 2014 Dec;30(4):e50-1. doi: 10.1097/YCT.0000000000000167. No abstract available.

PMID:
25054363
5.

[Ketamine for treatment of acute depression].

Hjerrild S, Bjerre J, Pedersen RH, Videbech P.

Ugeskr Laeger. 2013 Sep 9;175(37):2090-3. Review. Danish.

PMID:
24011203
6.

[Ketamine for treatment of therapy-resistant depression: a case study].

Segmiller F, Frisse D, Eser D, Möller HJ, Rüther T, Schüle C.

Nervenarzt. 2013 Jul;84(7):854-5. doi: 10.1007/s00115-012-3636-0. German. No abstract available.

PMID:
23143117
7.

Time-Course of Depression Improvement With Ketamine Adjunction in Electroconvulsive Therapy.

Romeo B, Choucha W, Fossati P, Rotge JY.

J ECT. 2016 Jun;32(2):80-1. doi: 10.1097/YCT.0000000000000293. No abstract available.

PMID:
26766630
8.

[Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy].

Gosek P, Chojnacka M, Bieńkowski P, Swiecicki Ł.

Psychiatr Pol. 2014 Jan-Feb;48(1):49-58. Polish.

PMID:
24946434
9.

Nonconventional interventions for chronic post-traumatic stress disorder: Ketamine, repetitive trans-cranial magnetic stimulation (rTMS), and alternative approaches.

Pradhan B, Kluewer D'Amico J, Makani R, Parikh T.

J Trauma Dissociation. 2016;17(1):35-54. doi: 10.1080/15299732.2015.1046101. Epub 2015 Jul 10. Review.

PMID:
26162001
10.

Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study.

Järventausta K, Chrapek W, Kampman O, Tuohimaa K, Björkqvist M, Häkkinen H, Yli-Hankala A, Leinonen E.

J ECT. 2013 Sep;29(3):158-61. doi: 10.1097/YCT.0b013e318283b7e9. Erratum in: J ECT. 2014 Jun;30(2):176. Dosage error in article text.

PMID:
23475029
11.

Ketamine: a new and immediate treatment for depression.

[No authors listed]

Nurse Educ. 2011 Nov-Dec;36(6):275. doi: 10.1097/NNE.0b013e3182333e0b. No abstract available.

PMID:
22024686
12.

Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.

De Gioannis A, De Leo D.

Aust N Z J Psychiatry. 2014 Jul;48(7):686. doi: 10.1177/0004867414520754. Epub 2014 Jan 22. No abstract available.

PMID:
24452289
13.

Ketamine as treatment for depression.

Taiminen T.

Duodecim. 2017;133(1):52-60. Review.

PMID:
29199810
14.

Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression.

Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, Epstein CM.

Depress Anxiety. 2010 Oct;27(10):960-3. doi: 10.1002/da.20731.

15.

Prolonged effect of an anesthetic dose of ketamine on behavioral despair.

Yilmaz A, Schulz D, Aksoy A, Canbeyli R.

Pharmacol Biochem Behav. 2002 Jan-Feb;71(1-2):341-4.

PMID:
11812542
16.

Case report: prehospital use of intranasal ketamine for paediatric burn injury.

Reid C, Hatton R, Middleton P.

Emerg Med J. 2011 Apr;28(4):328-9. doi: 10.1136/emj.2010.092825. Epub 2011 Feb 3.

PMID:
21292791
17.

Ketamine: repurposing and redefining a multifaceted drug.

Potter DE, Choudhury M.

Drug Discov Today. 2014 Dec;19(12):1848-54. doi: 10.1016/j.drudis.2014.08.017. Epub 2014 Sep 16. Review.

PMID:
25224017
18.

Ketamine and transcranial magnetic stimulation treatment for bipolar II disorder: a case report.

Best SR, Griffin BP, Pavel DG.

J Med Case Rep. 2015 Mar 31;9:73. doi: 10.1186/s13256-015-0520-0.

19.

Ketamine successfully terminates malignant status epilepticus.

Prüss H, Holtkamp M.

Epilepsy Res. 2008 Dec;82(2-3):219-22. doi: 10.1016/j.eplepsyres.2008.08.005. Epub 2008 Sep 19.

PMID:
18804344
20.

Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up.

Krupitsky E, Burakov A, Romanova T, Dunaevsky I, Strassman R, Grinenko A.

J Subst Abuse Treat. 2002 Dec;23(4):273-83.

PMID:
12495789

Supplemental Content

Support Center